欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/V/0610/001
药品名称Parofor 140 mg/ml Oral Solution for Non-Ruminant Calves
活性成分
    • PAROMOMYCIN SULFATE 200.0 mg/ml
剂型Oral solution
上市许可持有人Huvepharma N.V. Uitbreidingstraat 80 Antwerpen B-2600
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Parofor 140 mg/ml Oral Solution for Non-Ruminant Calves
    • Luxembourg (LU)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
      Parofor crypto 140 000 IU/ml šķīdums iekšķīgai lietošanai liellopiem pirms atgremošanas procesu sākšanās
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2019/02/13
最近更新日期2023/12/07
药物ATC编码
    • QP51AA06 nimorazole
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase